Kubota Pharmaceutical Holdings Co., Ltd.
4596.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.19 | 0.09 | 0.10 | -2.63 |
| FCF Yield | -41.68% | -31.50% | -37.85% | -37.17% |
| EV / EBITDA | -1.26 | -1.31 | -0.91 | -1.18 |
| Quality | ||||
| ROIC | -87.97% | -49.94% | -51.04% | -56.56% |
| Gross Margin | -1,919.17% | -148.03% | -685.01% | 0.00% |
| Cash Conversion Ratio | 0.90 | 0.90 | 1.04 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | 48.79% | – | -39.77% | -100.00% |
| Free Cash Flow Growth | 11.15% | 34.68% | 14.97% | -11.50% |
| Safety | ||||
| Net Debt / EBITDA | 1.18 | 1.88 | 2.01 | 1.49 |
| Interest Coverage | -166.48 | -148.66 | -182.63 | -145.56 |
| Efficiency | ||||
| Inventory Turnover | 54.50 | 2.75 | 0.78 | -1,558.89 |
| Cash Conversion Cycle | 55.11 | 32.94 | -1,996.66 | -462.88 |